BIOA CIK: 1709941

BioAge Labs, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−40.0
FY23:
−48.4
FY24:
−78.2
FY25:
−92.8
(positive)
Change from FY22 to FY25
millions USD
FY22:
−39.4
FY23:
−45.8
FY24:
−68.4
FY25:
−79.5
(positive)
Change from FY22 to FY25
millions USD
FY22:
−39.7
FY23:
−63.9
FY24:
−71.1
FY25:
−80.6
(positive)
Change from FY22 to FY25
millions USD
FY22:
−39.7
FY23:
−63.9
FY24:
−71.1
FY25:
−80.6

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data